tabersonine has been researched along with Innate Inflammatory Response in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chattipakorn, N; Chen, R; Chen, Y; Dai, C; Huang, W; Liang, G; Luo, W; Shen, S; Wang, J; Wang, Z | 1 |
| Chai, T; Nsanzamahoro, S; Sang, C; Shi, J; Wang, C; Wang, J; Yang, A; Yang, J | 1 |
| Chen, P; Chen, Y; Huang, W; Liang, G; Lin, W; Luo, W; Wang, X; Wu, G; Ye, B | 1 |
| Cao, S; Chen, Y; Lin, W; Liu, M; Qian, C; Sun, X; Wang, J; Wang, Y; Wu, H; Yang, J; Zhang, M | 1 |
4 other study(ies) available for tabersonine and Innate Inflammatory Response
| Article | Year |
|---|---|
Tabersonine attenuates Angiotensin II-induced cardiac remodeling and dysfunction through targeting TAK1 and inhibiting TAK1-mediated cardiac inflammation.
Topics: Angiotensin II; Animals; Cardiomegaly; Fibrosis; Heart Failure; Indole Alkaloids; Inflammation; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Quinolines; Rats; Signal Transduction; Ventricular Remodeling | 2022 |
Tabersonine Inhibits the Lipopolysaccharide-Induced Neuroinflammatory Response in BV2 Microglia Cells via the NF-
Topics: Anti-Inflammatory Agents; Humans; Inflammation; Inflammation Mediators; Interleukin-6; Lipopolysaccharides; Microglia; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Signal Transduction; Tumor Necrosis Factor-alpha | 2022 |
Tabersonine alleviates obesity-induced cardiomyopathy by binding to Transforming growth factor activated kinase 1 (TAK1) and inhibiting TAK1-mediated inflammation.
Topics: Animals; Inflammation; MAP Kinase Kinase Kinases; Mice; Mice, Obese; Obesity; Transforming Growth Factors | 2023 |
Tabersonine attenuates obesity-induced renal injury via inhibiting NF-κB-mediated inflammation.
Topics: Animals; Inflammation; Kidney; Kidney Diseases; Mice; NF-kappa B; Obesity | 2023 |